This inventor holds 5 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Pfizer Corporation, Other. Active years: 1992-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Dana Point, CA (US) (1992)
- Concord, MA (US) (2018 - 2024)
Company Filing History:
4 out of 4,492 
1 out of 834,708 Years Active: 1992-2026
Title: The Innovator Behind Diacylglycerol Acyl Transferase 2 Inhibitors: David A. Price
Introduction: David A. Price, a distinguished inventor based in Concord, MA, has made significant strides in the field of pharmacology. With three notable patents to his name, he focuses on developing innovative compounds aimed at treating diseases related to diacylglycerol acyltransferase 2 (DGAT2).
Latest Patents: Among David's latest patents are innovative inhibitors of diacylglycerol acyl transferase 2. These compounds, described under Formula I, target the activity of DGAT2 and have potential applications in treating various diseases in animals. His research emphasizes the importance of these compounds in medical treatments, showcasing his commitment to advancing health solutions.
Career Highlights: David A. Price has established a remarkable career within Pfizer Corporation, a leading global pharmaceutical company. His work has gained recognition due to its potential impact on therapeutic strategies, particularly in the realm of metabolic disorders.
Collaborations: Throughout his career, David has collaborated with notable colleagues, including Markus Boehm and Shawn Cabral. Together, they foster a collaborative environment that promotes innovation and drives progress in their technological advancements.
Conclusion: David A. Price stands out as a prominent inventor whose contributions to the field of pharmacology, particularly through his patents on diacylglycerol acyl transferase 2 inhibitors, reflect his dedication to developing new therapeutic solutions. His work at Pfizer Corporation and collaboration with esteemed colleagues highlight the importance of innovation in tackling significant medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile